GSA CAPITAL PARTNERS LLP - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 207 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$414,000
+87.3%
10,183
+92.5%
0.04%
+13.5%
Q1 2021$221,000
-73.3%
5,290
-72.7%
0.04%
-72.6%
Q4 2020$827,000
+41.9%
19,365
-12.7%
0.14%
+39.2%
Q3 2020$583,000
+23.5%
22,188
+26.0%
0.10%
-63.1%
Q2 2020$472,000
+55.8%
17,615
-0.1%
0.26%
+673.5%
Q2 2019$303,000
+43.6%
17,636
+34.6%
0.03%
+61.9%
Q1 2019$211,000
-34.3%
13,102
-40.3%
0.02%
-43.2%
Q4 2018$321,000
+4.6%
21,935
+29.8%
0.04%
+117.6%
Q3 2018$307,000
-79.6%
16,900
-81.1%
0.02%
-77.3%
Q2 2018$1,505,000
-25.5%
89,200
-13.5%
0.08%
-29.9%
Q1 2018$2,020,000
+755.9%
103,100
+428.7%
0.11%
+723.1%
Q3 2016$236,000
-54.3%
19,500
-67.4%
0.01%
-55.2%
Q2 2016$516,000
+40.6%
59,845
+54.6%
0.03%
+26.1%
Q1 2016$367,000
-43.2%
38,704
+3.8%
0.02%
-28.1%
Q4 2015$646,000
-34.3%
37,273
-49.1%
0.03%
-33.3%
Q3 2015$984,000
-55.8%
73,289
-25.7%
0.05%
-44.2%
Q2 2015$2,227,000
+124.3%
98,647
+41.8%
0.09%
+120.5%
Q1 2015$993,000
+114.9%
69,547
+45.1%
0.04%
+21.9%
Q4 2014$462,000
-9.4%
47,926
-14.5%
0.03%
+18.5%
Q3 2014$510,000
+172.7%
56,042
+195.4%
0.03%
+237.5%
Q2 2014$187,000
-70.1%
18,970
-61.5%
0.01%
-81.8%
Q1 2014$625,00049,2270.04%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$51,293,0007.24%
First Light Asset Management, LLC 2,050,273$93,103,0005.59%
TRAN CAPITAL MANAGEMENT, L.P. 1,350,870$61,343,0005.06%
SNYDER CAPITAL MANAGEMENT L P 3,176,404$144,241,0004.04%
DOHENY ASSET MANAGEMENT /CA 91,930$4,175,0002.69%
Redwood Investments, LLC 538,656$24,460,0001.97%
HighMark Wealth Management LLC 53,457$2,427,0001.78%
Taylor Wealth Management Partners 85,409$3,878,0001.37%
SILVERARC CAPITAL MANAGEMENT, LLC 66,673$3,028,0001.35%
Granite Investment Partners, LLC 919,029$41,733,0001.29%
View complete list of HALOZYME THERAPEUTICS INC shareholders